Three Share Nobel Prize for Hepatitis C Research

[ad_1]

Oct. 5, 2020 — Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.


Hepatitis C, which causes cirrhosis and liver cancer, causes 400,000 deaths worldwide each year, the Washington Post reported.

The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of the Washington University in St. Louis; and British-born virologist Michael Houghton.

The researchers’ work was described by the Nobel Committee as “a landmark achievement in our battle against viral infections,” the Post reported.



WebMD News from HealthDay



Copyright © 2013-2020 HealthDay. All rights reserved.



[ad_2]

Source link

731 thoughts on “Three Share Nobel Prize for Hepatitis C Research

Leave a Reply

Your email address will not be published.